Vimarsana
Biggest News Aggregation in the World

Exeter Science News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Exeter Science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Exeter Science Today - Breaking & Trending Today

The New York quant fund growing a secret team in Exeter - Vimarsana News

The New York quant fund growing a secret team in Exeter

The (Devon) cream rises to the top

IHG partners with Zeal Hotels for net zero carbon property in Exeter – Business Traveller - Vimarsana News

IHG partners with Zeal Hotels for net zero carbon property in Exeter – Business Traveller

The 142-room hotel is set to open next year and will be IHG’s “first lifecycle net zero carbon hotel”…

Red starts work on £22m Exeter hotel - Vimarsana News

Red starts work on £22m Exeter hotel

Red Construction South West has broken ground for a new £22m hotel in Exeter.

Expansion of university accelerator will benefit North Devon businesses - Vimarsana News

Expansion of university accelerator will benefit North Devon businesses

The partnership with the regional hubs will see the SETsquared Exeter team having a presence in the partner facilities in order to meet with start-up

Oxford/AstraZeneca vaccine 80% effective against B1.617.2 variant: UK study | India News - Vimarsana News

Oxford/AstraZeneca vaccine 80% effective against B1.617.2 variant: UK study | India News

LONDON: Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of Covid-19, first discovered in India, a new UK government study has reportedly found. The Oxford/AstraZeneca two-dose vaccine is also being produced by the Serum Institute of India as Covishield and being administered among the adult population in India to protect against the deadly virus. The UK findings are said to be based on data from Public Health England (PHE) and have also revealed that the two doses provide 87 per cent protecti...